Chest X Ray and C-reactive Protein as Diagnostic Modalities for Monitoring Complications of Mild to Moderate COVID-19 Infections: Experience from a Dedicated COVID Hospital, Kolkata
DOI:
https://doi.org/10.37506/wnnykq89Keywords:
COVID-19, Kolkata, CRP, Chest X-ray, cost-effectiveAbstract
Introduction: SARS-COV-2 has created havoc during 2019-2021. Diagnosis and managing complications needed both laboratory investigations and imaging modalities.
Aims and objectives: To find out the association between socio-demographic and clinical profiles of the study
subjects with their different laboratory investigations and imaging modalities and to compare normal investigations with their gold-standard variants.
Materials and Methods: During the first wave of COVID-19, a descriptive, observational, and cross-sectional
study was carried out on 120 consecutive samples of mild to moderate COVID patients using a convenience
sampling technique in a COVID indoor ward of Medical College, Kolkata. The semi-structured data collection
form used in the study was predesigned, pretested, face and content validated. SPSS version 25 and Microsoft Excel version 19 was used for data analysis after coding. Ethical approval was taken. (Ref No. MC/KOL/IEC/ Non-Spon/842/11/2020).
Results: Old age, uncontrolled diabetes and hypertension, presence of symptoms especially shortness of breath is significantly associated with low levels of SpO2, elevated C reactive protein (CRP) and D-dimer, abnormal Chest X-ray (CXR) and CT Thorax. A Kappa analysis suggested CRP and CXR can also be done instead of D-dimer and CT Thorax respectively, in a COVID patient for monitoring complications.
Conclusion: CRP and CXR are cost-effective alternatives and can be used as diagnostic modalities for monitoring of complications of mild to moderate COVID-19 infections.
References
Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang
CB, Bernardini S. The COVID-19 pandemic. Critical
reviews in clinical laboratory sciences. 2020 Aug
;57(6):365-88.
Fauci AS, Lane HC, Redfield RR. Covid-19—navigating
the uncharted. New England Journal of Medicine. 2020
Mar 26;382(13):1268-9.
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono
R, Costa F, Scarlata S, Agrò FE. COVID-19 diagnosis
and management: a comprehensive review. Journal of
internal medicine. 2020 Aug;288(2):192-206.
Ullah W, Thalambedu N, Haq S, Saeed R, Khanal S,
Tariq S, Roomi S, Madara J, Boigon M, Haas DC,
Fischman DL. Predictability of CRP and D-Dimer
levels for in-hospital outcomes and mortality of
COVID-19. Journal of community hospital internal
medicine perspectives. 2020 Sep 2;10(5):402-8.
Valerio L, Ferrazzi P, Sacco C, Ruf W, Kucher N,
Konstantinides SV, Barco S, Lodigiani C. Course of
D-dimer and C-reactive protein levels in survivors
and nonsurvivors with COVID-19 pneumonia: a
retrospective analysis of 577 patients. Thrombosis and
Haemostasis. 2021 Jan;121(01):098-101.
Mangal A, Kalia S, Rajgopal H, Rangarajan K,
Namboodiri V, Banerjee S, Arora C. CovidAID:
COVID-19 detection using CXR. arXiv preprint
arXiv:2004.09803. 2020 Apr 21.
Gündüz Y, Öztürk MH, Tomak Y. The usual course of
thorax CT findings of COVID-19 infection andwhen
to perform control thorax CT scan. Turkish Journal of
Medical Sciences. 2020;50(4):684-6.
Drug Misuse and Addiction | National Institute on
Drug Abuse (NIDA) (nih.gov) (last accessed on 30th
August, 2022)
Su Y, Ju MJ, Xie RC, Yu SJ, Zheng JL, Ma GG, et al.
Prognostic Accuracy of Early Warning Scores for
Clinical Deterioration in Patients With COVID-19.
Front Med (Lausanne). 2021;7: 624255.
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical
predictors of mortality due to COVID-19 based on an
analysis of data of 150 patients from Wuhan, China.
Intensive Care Med. 2020;46: 846-848.
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS,
Li YM, et al; China Medical Treatment Expert Group
for COVID-19. Comorbidity and its impact on 1590
patients with COVID-19 in China: a nationwide
analysis. Eur Respir J. 2020; 55: 2000547.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R,
Jabri A, et al. Clinical characteristics of Covid-19 in
New York City. N Engl J Med Overseas Ed 2020; 382:
–4.
Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et
al. C-reactive protein correlates with computed
tomographic findings and predicts severe COVID-19
early. J Med Virol. 2020; 92: 856–62.
Fan H, Zhang L, Huang B, Zhu M, Zhou Y, Zhang
H, et al. Cardiac injuries in patients with coronavirus
disease 2019: Not to be ignored. Int J Infect Dis. 2020;
: 294–7.
Cassone G, Dolci G, Besutti G, Muratore F, Bajocchi
G, Mancuso P, et al. Acute-phase reactants during
tocilizumab therapy for severe COVID-19 pneumonia.
Clin Exp Rheumatol. 2020; 38: 1215-1222.
Isakadze N, Engels MC, Beer D, McClellan R, Yanek
LR, Mondaloo B, et al. C-reactive Protein Elevation Is
Associated With QTc Interval Prolongation in Patients
Hospitalized With COVID-19. Front Cardiovasc Med.
; 9: 866146.
Prasetya IB, Cucunawangsih, Lorens JO, Sungono
V, El-Khobar KE, Wijaya RS. Prognostic value of
inflammatory markers in patients with COVID-19
in Indonesia. Clin Epidemiol Glob Health. 2021; 11:
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX,
Chong M, et al. Characteristics and Outcomes of 21
Critically Ill Patients With COVID-19 in Washington
State. JAMA. 2020; 323: 1612-1614.
Hanif N, Rubi G, Irshad N, Ameer S, Habib U, Zaidi
SRH. Comparison of HRCT Chest and RT-PCR in
Diagnosis of COVID-19. J Coll Physicians Surg Pak.
; 31: S1-S6.
Kim HW, Capaccione KM, Li G, Luk L, Widemon RS,
Rahman O, et al. The role of initial CXR in triaging
patients with suspected COVID-19 during the
pandemic. Emerg Radiol. 2020; 27: 617-621.
Wong HYF, Lam HYS, Fong AHT, Leung ST, Chin
TWY, Lo CSY, et al. Frequency and distribution of
chest radiographic findings in COVID-19 positive
patients. Radiology 2019; 27: 201160
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.